Amanda Grant Smith, M.D

Amanda Grant Smith, M.D.

Office: University of South Florida Eric Pfeiffer Suncoast Alzheimer’s & Gerontology Center At the USF Health Byrd Alzheimer’s Institute 4001 E. Fletcher Avenue Tampa, Florida 33613 Phone: (813)974‐4355 Fax (813)974‐4251 Email: [email protected]

Date of Birth: July 8, 1970 Place of Birth: Philadelphia, PA Maiden Name: Amanda Lauren Grant Social Security Number: Available upon request

EDUCATION

August 2001‐September 2002 Fellowship in Geriatric Psychiatry University of South Florida College of Medicine Tampa, FL

July 1998‐August 2001 Residency in General Psychiatry University of South Florida College of Medicine Tampa, FL

July 1997‐June 1998 Internship in Psychiatry University of South Florida College of Medicine Tampa, FL

September 1993‐May 1997 M.D. Jefferson Medical College of Thomas Jefferson University Philadelphia, PA

August 1992‐May 1993 Medical Science Track Program Hahnemann University Philadelphia, PA

August 1988‐May 1992 B.A. in Psychology B.A. in Biology Emory University Atlanta, GA

CERTIFICATION AND LICENSURE

Diplomate of the American Board of Psychiatry and Neurology, Inc. May 2003 with Subspecialty Qualification in Geriatric Psychiatry April 2004 Florida License ME 77616 Federal DEA number available upon request

CLINICAL APPOINTMENTS

July 2009‐ present Medical Director USF Health Byrd Alzheimer’s Center & Eric Pfeiffer Suncoast Alzheimer’s & Gerontology Center University of South Florida Tampa, FL

September 2008‐July 2009 Interim Director Eric Pfeiffer Suncoast Alzheimerʹs & Gerontology Center University of South Florida Tampa, FL

June 2008‐August 2008 Acting Interim Director USF Suncoast Alzheimer’s and Gerontology Center Tampa, FL

July 2004‐May 2008 Assistant Director USF Suncoast Alzheimer’s and Gerontology Center Tampa, FL

September 2002‐July 2004 Faculty Physician USF Suncoast Gerontology Center Tampa, FL

ACADEMIC APPOINTMENTS

September 2003‐present Assistant Professor Department of Psychiatry and Behavioral Medicine University of South Florida College of Medicine Tampa, FL

September 2002‐September 2003 Visiting Instructor Department of Psychiatry and Behavioral Medicine University of South Florida College of Medicine Tampa, FL

HONORS AND AWARDS

Class of 2007 USF Health Leadership Institute

January 2007 Joseph and Dora Camden Memorial Award for Suncoast Alzheimer’s and Gerontology Center’s Most Valued Employee, 2006

January 2006 Director’s Award for Outstanding Service, Suncoast Alzheimer’s and Gerontology Center Development Board

January 2005 Joseph and Dora Camden Memorial Award for Suncoast Alzheimer’s and Gerontology Center’s Most Valued Employee, 2004

September 2003 Joseph and Dora Camden Memorial Award for Suncoast Gerontology Center’s Most Valued Employee, July‐September 2003

October 2002 Edith P. Freedman Fellowship Suncoast Gerontology Center

June 2001 Chairman’s Award for Scholarly and Creative Activity Department of Psychiatry and Behavioral Medicine University of South Florida College of Medicine

November 2001 John Adams Award, Florida Psychiatric Society

January 1999‐November 2000 Ginsburg Fellow, Group for the Advancement of Psychiatry

ADMINISTRATIVE AND COMMITTEE POSITIONS

February 2009‐ present Member, Subcommittee on consent of cognitively impaired subjects, USF Institutional Review Board

2008‐present Member, Steering Committee, Alzheimerʹs Disease Cooperative Study

2008‐present Member, USF Clinical and Translational Scientific Institute & Neuroscience Signature Program Protocol Review Committee

July 2006‐present Member, University of South Florida Institutional Review Board Medical Board IRB‐01A

2005‐2006 Auction Chair, USF Suncoast Alzheimer’s and Gerontology Center annual Victory Ball

2005‐2008 Site Representative, Steering Committee, Alzheimerʹs Disease Cooperative Study

2005‐present Member, Executive Committee of the Development Board, USF Suncoast Alzheimer’s and Gerontology Center

2004‐ 2008 Member, Recruitment Committee, Department of Psychiatry and Behavioral Medicine, USF College of Medicine

2004‐present Member, Development Board, USF Suncoast Alzheimer’s and Gerontology Center

2003‐2008 Member, Research Committee, Department of Psychiatry and Behavioral Medicine, USF College of Medicine

2003‐ 2006 Psychiatry Representative, CPE Advisory Committee, USF College of Medicine

2003‐present Member, Institute on Aging/Collaborative on Aging, USF

2002‐present Member, Executive Committee USF Suncoast Alzheimer’s and Gerontology Center

2000‐2001 Psychiatry Representative, Utilization Review Committee James A. Haley VA Medical Center, Tampa, FL

1999‐2000 Fellow, Committee on Aging, Group for the Advancement of Psychiatry

1997‐1999 Member, Education Committee Department of Psychiatry and Behavioral Medicine University of South Florida College of Medicine

RESEARCH ACTIVITIES

2010 Principal Investigator: A Controlled Pilot Study of the Appliation of Magnetic Fields Using the Resonator in Adjunctive Management of Alzheimer’s Dementia. Pico‐Tesla Magnetic Therapies, LLC.

2010 Study Physician: An Open‐Label, Non‐Randomized Study to Evaluate the Efficacy and Safety of BAY 94‐9172 (ZK 6013443) Positron Emission Tomography (PET) Imaging for Detection/Exclusion of Cerebral Beta‐Amyloid When Compared to Postmortem Histopathology. BHC14595. Bayer Health Care.

2009 Principal Investigator, Study physician: A Multi‐Center, Randomized, Double Blind, Placebo‐Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic effects of BMS‐708163 in the Treatment of Patients with Prodromal Alzheimer’s Disease. CN156018. Bristol‐Myers Squibb.

2009 Principal Investigator, Study physician: A Multi‐Center, Randomized, Double Blind, Placebo‐Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic effects of BMS‐708163 in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease. CN156013. Bristol‐Myers Squibb.

2009 Sub‐investigator, Study physician. A Phase 3, Multi‐Center, Randomized, Double‐Blind Placebo‐Controlled Study to Evaluate the Safety and Tolerability of Dimebon (PF‐01913539) For Up to 26‐Weeks in Patients With Mild to Moderate Alzheimer’s Disease. B1451027. Pfizer.

2008 Co‐Principal Investigator: Education Core of Florida ADRC. (William Haley‐ PI)

2008 Principal Investigator, Study Physician: A Randomized, Double‐ Blind, Placebo‐Controlled, Dose‐Ranging, Safety and Efficacy Study of Oral ELND005 (AZD‐103) in Alzheimer’s Disease. ELND005‐AD201. Élan Pharmaceuticals, Inc.

2008 Sub‐investigator, Study Physician: Effect of gamma‐Secretase Inhibition on the Progression of Alzheimer’s Disease: LY450139 Versus Placebo. Protocol H6L‐MC‐LFAN (b). Eli Lilly & Co.

2008 Principal Investigator, Study Physician: A Double‐Blind, Placebo‐Controlled, Randomized, Multicenter Study Evaluating the Efficacy and Safety of Eighteen Months of Treatment with PF‐04494700 (TTP488) in Participants with Mild to Moderate Alzheimer’s Disease. ADCS‐RAGE; Pfizer B0341002. Alzheimer’s Disease Cooperative Study and Pfizer.

2007 Principal Investigator (2008), Sub‐investigator, Study Physician: A Randomized, Double‐blind, Placebo‐controlled, Add‐on Three‐arm Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IVIG, 10%) for the Treatment of Mild to Moderate Alzheimer’s Disease. ADCS‐GLAD; Baxter 160701. Alzheimer’s Disease Cooperative Study and Baxter Healthcare Corporation.

2007 Principal Investigator (2008), Sub‐investigator, Study Physician: A Phase III, Multicenter, Randomized, Double‐blind, Placebo‐ controlled, Parallel‐group, Efficacy and Safety Trial of Bapineuzumab (AAB‐001, ELN115727) In Patients with Mild to Moderate Alzheimer’s Disease who are Apolipoprotein E4 Non‐ carriers. ELN115727‐301. Élan Pharmaceuticals, Inc, & Wyeth.

2007 Principal Investigator (2008), Sub‐investigator, Study Physician: A Phase III, Multicenter, Randomized, Double‐blind, Placebo‐ controlled, Parallel‐group, Efficacy and Safety Trial of Bapineuzumab (AAB‐001, ELN115727) In Patients with Mild to Moderate Alzheimer’s Disease who are Apolipoprotein E4 Carriers. ELN115727‐302. Élan Pharmaceuticals, Inc, & Wyeth.

2007 Principal Investigator (2008), Sub‐investigator, Study Physician: Open Label Study of the Effect of Daily Treatment with MPC‐ 7869 in Subjects with Mild Dementia of the Alzheimer’s Type. MPC‐7869‐05‐009. Myriad Pharmaceuticals, Inc.

2007 Principal Investigator (2008), Sub‐investigator, Study Physician: Multi‐Center Trial to Evaluate Home‐Based Assessment Methods for Alzheimer Disease Prevention Research in People Over 75 Years Old. ADC‐030‐HBA. Alzheimer’s Disease Cooperative Study.

2006 Principal Investigator (2008), Sub‐investigator, Study Physician: A Randomized Double‐Blind Placebo‐Controlled Trial of the Effects of Docosahexaenoic Acid (DHA) in Slowing the Progression of Alzheimer’s Disease. ADC‐027‐DHA. Alzheimer’s Disease Cooperative Study.

2006 Principal Investigator (2008), Sub‐investigator, Study Physician: A Phase 3 Multinational, Randomized, Double‐blind, Placebo‐ controlled Study of the Effect of Daily Treatment with MPC‐7869 on Measures of Cognition, Activities of Daily Living, and Global Function in Subjects with Mild Dementia of the Alzheimer’s Type. MPC‐7869‐05‐010. Myriad Pharmaceuticals, Inc.

2006 Sub‐Investigator, Study Physician: A 54‐week, Double‐Blind, Randomized, Placebo‐Controlled, Parallel‐Group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy to Acetylcholinesterase Inhibitors on Cognition and Overall Clinical Response in APOE 4 Stratified Subjects with Mild to Moderate Alzheimer’s Disease. AVA102670. Glaxo‐SmithKline.

2006 Sub‐investigator, Study Physician: An Open‐Label Extension Study Evaluating the Safety and Tolerability of Memantine in Patients with Moderate to Severe Dementia of the Alzheimer’s Type. MEM‐MD‐54. Forest Research Institute.

2006 Sub‐investigator, Study Physician: An Open‐Label Extension of the Phase III Study CL‐758007 with AlzhemedTM in Patients with Alzheimer’s Disease. Neurochem, Inc.

2006 Sub‐investigator, Clinical and Education Cores. Florida ADRC. (NIA‐funded.)

2006 Sub‐Investigator, Study Physician: NTB Longitudinal Study. ELN‐AIP‐901. Élan Pharmaceuticals, Inc.

2006 Sub‐investigator, Study Physician: A Double‐Blind, Randomized, Placebo Controlled Study of the Efficacy, Safety and Tolerability of 8 week Treatment of Rozerem 8mg (QHS) in Sleep Disturbed, Community Dwelling, Mild to Moderately Severe Alzheimer’s Disease Subjects. 01‐05‐TL‐375‐061. Takeda Global Research and Development Center, Inc.

2005 Sub‐investigator, Study Physician: A Multicenter, Randomized, Double‐Blind, Long‐Term Extension Study to Determine the Safety, Tolerability, and Preliminary Long‐Term Efficacy of Lecozotan (SRA‐333) SR in Patients with Mild to Moderate Alzheimer’s Disesase Treated with a Cholinesterase Inhibitor. 3098B1‐204‐WW. Wyeth Research.

2005 Sub‐investigator, Study Physician: A 6‐Month, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter, Safety, Tolerability And Efficacy Study Of 3 Doses Of Lecozotan (SRA‐ 333) SR In Outpatients With Mild To Moderate Alzheimer’s Disease Treated with a Cholinesterase Inhibitor. 3098B1‐203‐ WW. Wyeth Research.

2005 Sub‐investigator, Study Physician: A 3‐Month, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter, Safety, Tolerability And Efficacy Study Of 3 Doses Of Lecozotan (SRA‐ 333) SR In Outpatients With Mild To Moderate Alzheimer’s Disease With Donepezil As Active Control. 3098B1‐201‐WW. Wyeth Research.

2005 Sub‐investigator, Study Physician: An Exploratory Study with Open‐Label Memantine: Assessment of Selected Measures of Volumetric MRI and Cognition in Patients with Moderate Dementia of the Alzheimer’s Type. MEM‐MD‐15. Forest Research Institute

2005 Sub‐investigator, Study Physician: A Randomized, Double‐ Blind, Placebo‐Controlled Evaluation of the Safety and Efficacy of Memantine in Patients with Moderate to Severe Dementia of the Alzheimer’s Type. MEM‐MD‐50. Forest Research Institute.

2005 Principal Investigator (2008), Sub‐investigator, Study Physician: A Phase 3 Multicenter, Randomized, Double‐blind, Placebo‐ controlled Study of the Effect of Daily Treatment with MPC‐7869 on Measures of Cognitive and Global Function in Subjects with Mild Dementia of the Alzheimer’s Type. MPC‐7869‐04‐005. Myriad Pharmaceuticals, Inc.

2004 Sub‐investigator, Study Physician: A Phase III Study of the Efficacy and Safety of Alzhemed in Patients with Mild to Moderate Alzheimer’s Disease. CL‐758007. Neurochem, Inc.

2004 Study Physician: Galantamine ER Open‐label Rapid Dose Escalation Trial in Alzheimer’s Disease. GAL‐ALZ‐303. Janssen Medical Affairs, L.L.C.

2004 Principal Investigator (2008), Sub‐investigator, Clinical Study Coordinator, Study Physician: A Multi‐center, Double‐blind, Placebo‐controlled Therapeutic Trial to Determine Whether Natural Huperzine A Improves Cognitive Function. ADC‐023‐ HU. Alzheimer’s Disease Cooperative Study.

2003 Study Physician: A Randomized, Multi‐center, Double‐blind, Placebo‐controlled, 18‐month Study on Cognitive Function and Global Decline of Xaliproden in Comparison to Placebo in Patients with Dementia of the Alzheimer’s Type. EFC2946. Sanofi‐Synthelabo Research.

2003 Study Physician: A One‐year, Multi‐center, Randomized, Placebo‐controlled Evaluation of the Efficacy and Safety of Donepezil Hydrochloride (E2020) in Subjects with Mild Cognitive Impairment. E2020‐A001‐412. Eisai/Pfizer Inc.

2003 Study Physician: An Evaluation of the Long‐term Safety and Efficacy of Neramexane in Patients with Moderate to Severe Dementia of the Alzheimer’s Type. NER‐MD‐03. Forest Research Institute.

2003 Study Physician: A Randomized, Double‐blind, Placebo‐ controlled Trial of Valproate to Attenuate the Progression of Alzheimer’s Disease (AD). ADC‐022‐VN. Alzheimer’s Disease Cooperative Study.

2003 Clinical Study Coordinator, Study Physician: A Prospective, 26‐ Week, Open‐label, Single‐arm, Multi‐center Study Evaluating the Efficacy and Safety of Exelon (rivastigmine tartrate) 3‐ 12mg/day in Patients with Mild to Moderate Alzheimer’s Disease Who Are Responding Poorly to Aricept (donepezil) Treatment. CENA713BUS13. Novartis Pharmaceuticals Corp.

2003 Clinical Study Coordinator, Study Physician: A Double‐Blind, Flexible Dose Comparison of the Safety and Efficacy of Escitalopram and Placebo in the Treatment of Geriatric Depression. SCT‐MD‐13. Forest Research Institute.

2003 Study Physician: High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer’s Disease. ADC‐016. Alzheimer’s Disease Cooperative Study.

2003 Study Physician: A Randomized, Double‐Blind, Placebo‐ Controlled Evaluation of the Safety and Efficacy of Neramexane in Patients with Moderate to Severe Dementia of the Alzheimer’s Type. NER‐MD‐01. Forest Research Institute.

2003 Study Physician: A Multi‐center, Randomized, Double‐Blind, Placebo‐Controlled Trial of Simvastatin to Slow the Progression of Alzheimer’s Disease. ADC‐015. Alzheimer’s Disease Cooperative Study.

2003 Study Physician: A Phase II Double‐Blind, Randomized, Dose‐ Ranging, Placebo‐Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer’s Type. 1198.052. Boehringer Ingelheim Pharmaceuticals, Inc.

2002 Study Physician: A 24 Week, Multi‐center, Randomized, Double‐ blind, Placebo‐controlled Evaluation of the Safety and Efficacy of Donepezil Hydrochloride (E2020) in Patients with Severe Alzheimer’s Disease Followed by a 12 Week Open‐label Period. E2020‐A001‐315. Eisai/Pfizer Inc.

2002 Study Physician, Rater: Comparative Effectiveness of Antipsychotic Medications in Patients with Alzheimer’s Disease. Clinical Antipsychotic Trials in Intervention Effectiveness. NIMH contract #N01MH90001.

2002 Study Physician: Efficacy and Safety of CX516 (900mg t.i.d.) in Elderly Participants with Mild Cognitive Impairment. A Randomized, Double‐blind, Placebo‐controlled, Parallel‐group 4‐week study. CORX‐CX516‐012.1 Cortex Pharmaceuticals.

2002 Sub‐investigator; Clinical Study Coordinator: A Pilot Study of Dilute Tropicamide as a Non‐invasive Test for Alzheimer’s Disease. (E. Pfeiffer and H. Potter, co‐PI’s.)

2002 Study Physician: A Randomized, Double‐blind, Placebo‐ controlled Evaluation of the Safety and Efficacy of Memantine in Patients with Moderate to Severe Dementia of the Alzheimer’s Type. MEM‐MD‐01. Forest Research Institute.

2002 Study Physician: A Long‐Term Extension Study Evaluating the Safety and Tolerability of Four Memantine Dosing Regimens in Patients with Moderate to Severe Dementia of the Alzheimer’s Type. MEM‐MD‐03. Forest Research Institute.

2002 Study Physician: A Randomized, Double‐blind, Placebo‐ controlled Evaluation of the Safety and Efficacy of Memantine in Patients with Mild to Moderate Dementia of the Alzheimer’s Type. MEM‐MD‐12. Forest Research Institute.

2002 Study Physician: Assessment Measures for Alzheimer’s Disease Primary Prevention Trials. ADC‐013. Alzheimer’s Disease Cooperative Study.

2002 Study Physician: The Safety and Efficacy of MK‐0966 for the Prevention of Alzheimer’s Disease in Patients at Risk. MK‐0966‐ 078‐00. Merck & Co., Inc.

2002 Study Physician: A Randomized, Double‐blind, Placebo‐ controlled Trial to Evaluate the Safety and Efficacy of Vitamin E and Donepezil HCl (Aricept) to Delay Clinical Progression from Mild Cognitive Impairment (MCI) to Alzheimer’s Disease (AD). ADC‐008. Alzheimer’s Disease Cooperative Study.

1999‐2002 University of South Florida Memory Disorders Clinic (Roskamp Institute) and USF Suncoast Gerontology Center, Tampa, FL. Participant in interviews to screen patients for enrollment in research studies of dementia.

1990‐1992 Grady Memorial Hospital MRI Center, Atlanta, GA. Research assistant to Emory University physics professor, Dr. John Malko. Studied cerebrospinal fluid using magnetic resonance imaging to find a standard by which to measure brain atrophy in alcoholism and Alzheimer’s disease. Studied effect of magnetic field on growth of yeast.

OTHER SCHOLARLY ACTIVITY

“Dementia.” James A. Haley VA Medical Center Geriatric Medicine Lecture series. September 12, 2008. Tampa, FL.

“New Directions in Alzheimer’s Treatment and Research.” 116th Annual Convention of the Florida Pharmacy Association. July 12, 2008. Orlando, FL.

“New Directions in Alzheimer’s Clinical Research.” 10th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Alzheimer’s & Gerontology Center, USF Geriatric Education Center, USF School of Aging Studies, and USF College of Nursing. June 13, 2008. Tampa, FL.

“Advances in the Diagnosis and Treatment of Alzheimer’s Disease.” What Caregivers Need to Know sponsored by the USF Suncoast Gerontology Center. May 1, 2008. Plant City, FL

“Recognition and Management of Alzheimer’s Disease and Related Dementias in the Skilled Nursing Facility.” Florida chapter of the American Society of Consultant Pharmacists Annual Conference. April 12, 2008. Tampa, FL.

“Advances in the Diagnosis and Treatment of Alzheimer’s Disease.” What Caregivers Need to Know sponsored by Aston Gardens and the USF Suncoast Gerontology Center. February 28, 2008. Tampa, FL.

“Optimizing Pharmacotherapeutic Benefit in Alzheimer’s Disease: Keys to Effective Disease Management.” Meeting of the Florida chapter of the American Society of Consultant Pharmacists. January 29, 2008. Ft. Lauderdale, FL.

“Dementia.” Medical Student Psychiatry Interest Coalition. USF College of Medicine. December 5, 2007. Tampa, FL.

“Transdermal Therapy: A New Technology in Alzheimer’s Disease.” Meeting of the Greater Tampa Bay Psychiatric Society. November 7, 2007. Tampa, FL.

“Understanding Dementia.” James A. Haley VA Medical Center Geriatric Medicine Lecture series. September 14, 2007. Tampa, FL.

“Treatment of Dementia and Related Behavioral Problems.” Brandon Regional Hospital. September 12, 2007. Brandon, FL

“Understanding Dementia.” 44th Annual Conference of the Florida Association of Homes and Services for the Aging. July 31, 2007. Orlando, FL.

Geriatric Case Conference on Dementia, 3rd year medical student psychiatry clerkship. Every other month, June 2007‐December 2007.

“Lewy Body Dementia.” 9th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Alzheimer’s & Gerontology Center, USF Geriatric Education Center, USF School of Aging Studies, and USF College of Nursing. June 13, 2007. Tampa, FL.

“Medications for Treating Alzheimer’s Disease and Behavior Management.” Brandon Regional Hospital Lecture Series. February 21, 2007. Brandon, FL.

“Lifestyle Changes that May Prevent Alzheimer’s Disease.” USF Health Mini Med School. February 5, 2007. Tampa Bay Performing Arts Center, Tampa, FL.

“Medications for Treating Alzheimer’s Disease and Related Behavioral Problems.” Palm Harbor Community Center Alzheimer’s Support Group. January 22, 2007. Palm Harbor, FL

“Differentiating Dementia from Depression” and “Management of Behavioral Problems in Dementia.” River Garden Hebrew Home Community Lecture Series in conjunction with the University of Florida, Gainesville. October 24, 2006. Jacksonville, FL.

“Advances in the Diagnosis and Treatment of Alzheimer’s Disease.” James A. Haley VA Medical Center Geriatric Medicine Lecture series. October 6, 2006. Tampa, FL.

“When the Dementia Diagnosis Isn’t Alzheimer’s.” Professional Guardian Association of Pinellas County Annual Conference. September 29, 2006. St. Petersburg, FL.

“Dealing with Alzheimer’s Disease and Dementia: State of the Art Treatment and System Approaches.” Panel discussion, Seniors in Florida: Protecting the Golden Years. A 21st Century Summit. September 8, 2006. Tampa, FL.

Outpatient clinical supervisor for ARNP Clinical Doctorate candidate. September 2006

“Lifestyle Changes that May Prevent Alzheimer’s Disease.” 8th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Gerontology Center, USF Geriatric Education Center, USF Department of Gerontology, and USF College of Nursing. June 8, 2006. Tampa, FL.

“Pharmacologic Approaches to Behavior Management in Dementia.” 8th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Gerontology Center, USF Geriatric Education Center, USF Department of Gerontology, and USF College of Nursing. June 8, 2006. Tampa, FL.

“Will a Healthy Lifestyle Prevent Alzheimer’s Disease?” University of South Florida Department of Psychiatry and Behavioral Medicine Geriatric Lecture series. January 27, 2006. Tampa, FL.

“Advances in the Diagnosis and Treatment of Alzheimer’s Disease.” University of South Florida Department of Psychiatry and Behavioral Medicine Grand Rounds. December 9, 2005. Tampa, FL.

“Advances in the Diagnosis and Treatment of Alzheimer’s Disease.” James A. Haley VA Medical Center Geriatric Medicine Lecture series. November 18, 2005. Tampa, FL.

“Alzheimer’s 101.” St. Petersburg MOAA chapter luncheon. September 16, 2005. St. Petersburg, FL.

Outpatient clinical supervisor for Geriatric Medicine fellow. September 2005

“The Cutting Edge: Alzheimer’s Disease and Related Dementias.” Journey through Aging sponsored by USF Lakeland. August 27, 2005. Lakeland, FL.

“Overview: Understanding Alzheimer’s Disease.” University of South Florida Employee Assistance Program Summer Workshop. July 26, 2005. Tampa, FL.

Geriatric Case Discussion on Depression and Pseudodementia, 3rd year medical student psychiatry clerkship. Every other month, June 2005‐April 2007.

“Grief and Its Effect on the Decision to Place a Demented Loved One in Long‐Term Care.” Poster Presentation. Future Leaders in Psychiatry sponsored by Emory University School of Medicine. April 16, 2005. Palm Beach, FL.

“The Diagnosis and Management of Dementia.” Neurology in the New Millennium sponsored by the USF Department of Neurology. October 30, 2004. Tampa, FL.

Enrichment supervisor to PGY‐3 psychiatry resident(s). Weekly, 2004‐present.

Thesis Director for undergraduate honors student at USF. 2004‐5 academic year.

“Alzheimer’s 101 with Research Updates.” Alzheimer’s Disease Seminar for Caregivers and Professionals sponsored by the Alzheimer’s Family Organization. September 8, 2004. Hudson, FL.

“When Memory Loss Is Not Alzheimer’s: Understanding Depression and the Other Dementias.” Alzheimer’s Disease: What Health Professionals Need to Know sponsored by USF Suncoast Gerontology Center and Lakeland Regional Medical Center. December 2, 2003. Lakeland, FL.

Thesis Director for undergraduate honors student at USF. 2003‐4 academic year.

“Management of Difficult Behavior Problems in Dementia.” Alzheimer’s Disease: What Caregivers Need to Know sponsored by USF Suncoast Gerontology Center. October 1, 2003. Tampa, FL.

“Psychiatric Management of Dementia.” Strategies and Solutions in Geriatric Care. 5th Annual University of South Florida Geriatric Institute sponsored by USF Suncoast Gerontology Center, USF Geriatric Education Center, USF Department of Gerontology, and USF College of Nursing. June 11, 2003. Tampa, FL.

Geriatric psychiatry lectures on “Geriatric Depression” and “Management of Behavioral Symptoms in Dementia.” 3rd year medical student psychiatry clerkship. Every other month, July 2003‐ June 2005.

Outpatient clinical supervisor, 3rd year medical student psychiatry clerkship, geriatric medicine outpatient clerkship, and 4th year medical student psychiatry electives. 2003‐present.

“Alzheimer’s Disease Update.” Alzheimer’s 2nd Educational Seminar sponsored by Samaritans Alzheimer’s Auxiliary. February 26, 2003. Sun City Center, FL.

“Mealtime and Nutrition in the Middle and Late Stages.” Alzheimer’s Disease: What Caregivers Need to Know sponsored by USF Suncoast Gerontology Center. February 12, 2003. Tampa, FL.

“Eating‐Related Problems in Dementia Patients.” University Village nursing home staff. November 19, 2002. Tampa, FL.

Clinical supervisor to geriatric psychiatry fellow. Weekly, 2002‐present.

“Topiramate Overdose: A Case Report and Literature Review.” Fall meeting of the Florida Psychiatric Society. November 3, 2001. Miami, FL.

Examiner for Clinical Practice Exercise. Department of Psychiatry and Behavioral Medicine, University of South Florida College of Medicine. Annually, 2000‐present.

Led small group seminars for first year medical students as part of their Introduction to Behavioral Medicine course. University of South Florida College of Medicine. Annually, 2000‐2006.

PROFESSIONAL AFFILIATIONS

American Association for Geriatric Psychiatry International Psychogeriatric Association Alzheimer’s Association International Society to Advance Alzheimer Research and Treatment (ISTAART) Novartis Speaker’s Bureau

PUBLICATIONS

Smith, AG: Why is the Room Spinning? The Tampa Tribune (4 You), January 3, 2009.

Smith, AG: How Can Caregivers Take Care of Themselves? The Tampa Tribune (4 You), August 23, 2008.

Smith, AG: Can Tiny Strokes Cause Memory Loss? The Tampa Tribune (4 You), May 31, 2008.

Smith, AG: Do You Have To Tell Your Doctor Everything? The Tampa Tribune (4 You), March 1, 2008.

Smith, AG: How Do I Get a Good Night’s Sleep? The Tampa Tribune (4 You), November 10, 2007.

Smith, AG: How Can You Prevent Fall‐Related Injuries? The Tampa Tribune (4 You), August 11, 2007.

Smith, AG: Coping with the Changes in Medicine that Affect Residency Training, in Foreman, T, Dickstein, LJ, Garakani, A (eds): A Resident’s Guide to Surviving Psychiatric Training, 2nd Edition. American Psychiatric Association, Arlington, VA, 2007. pp138‐139.

Smith, AG: Dealing with Managed Care in the Outpatient Setting, in Foreman, T, Dickstein, LJ, Garakni, A (eds): A Resident’s Guide to Surviving Psychiatric Training, 2nd Edition. American Psychiatric Association, Arlington, VA, 2007. pp140‐142.

Smith, AG: What Can I Do About the Shaking in my Hands? The Tampa Tribune (4 You), May 19, 2007.

Smith, AG: What Can Be Done About Hearing Loss? The Tampa Tribune (4 You), March 3, 2007.

Editorial Board Consultant, American Journal of Geriatric Pharmacotherapy 2007.

Smith, AG: When Does Grieving Turn in to Depression? The Tampa Tribune (4 You), January 27, 2007.

Smith, AG: Dementia Can Have a Variety of Causes. The Tampa Tribune (4 You), November 4, 2006.

Smith, AG: Exercise Your Mind With Your Body. The Tampa Tribune (4 You), September 16, 2006.

Smith, AG: Intimacy Doesn’t Have to Decrease With Age. The Tampa Tribune (4 You), August 5, 2006.

Smith, AG: Is it Time to Stop Driving? The Tampa Tribune (4 You), May 13, 2006.

Reviewer for Evashwick, C: The Continuum of Long‐Term Care, 3rd Ed. Thomson Delmar Learning, Clifton Park, NY, 2004.

Smith, AG: Behavioral Problems in Dementia: Strategies for Pharmacologic and Non‐ pharmacologic Mangagement. Postgraduate Medicine 2004; 115(6): 47‐56.

Smith, AG: Coping with the Changes in Medicine that Affect Residency Training, in Foreman‐El‐ Masri, TA, Dickstein, LJ (eds): A Resident’s Guide to Surviving Psychiatric Training. American Psychiatric Association, Arlington, VA, 2003. pp86‐87.

Smith, AG: Dealing with Managed Care in the Outpatient Setting, in Foreman‐El‐Masri, TA, Dickstein, LJ (eds): A Resident’s Guide to Surviving Psychiatric Training. American Psychiatric Association, Arlington, VA, 2003. pp88‐89.

Reviewer, Journal of Mental Health and Aging 2003.

Smith, AG; Montealegre‐Orjuela M; Douglas JE; Jenkins EA. Venlafaxine for Pathological Crying After Stroke. Journal of Clinical Psychiatry 2003; 64(6): 731‐732.

Smith, AG; Brauer, HR; Catalano, G; Catalano, MC. Topiramate Overdose: A Case Report and Literature Review. Epilepsy and Behavior 2001; 2(6): 603‐607.

PERSONAL

Married to Sam E. Smith (1997) Children (2): Marielle Leah Smith (2000), Madeleine Isabella Smith (2002) Hobbies and interests: arts and crafts, music, dog rescue, photography, reading, creative writing, NFL football, travel Alumnus of the Delta Alpha chapter of Alpha Delta Pi sorority

REFERENCES

Available upon request.